Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion type Assertion NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_head.
- NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion description "[CD166 immunoreactivity in malignant tumors (adenoid cystic carcinoma (ACC) and mucoepidermoid carcinoma (MEC)) (56.7?�?14.05) was significantly higher than that of pleomorphic adenoma (PA) (34.3?�?17.07) (P?<?0.000) and higher in the PA than normal salivary gland (13.2?�?12.1) (P?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_provenance.
- NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion evidence source_evidence_literature NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_provenance.
- NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion SIO_000772 25472586 NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_provenance.
- NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion wasDerivedFrom befree-2016 NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_provenance.
- NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_assertion wasGeneratedBy ECO_0000203 NP1244606.RA1UFaXYpE7WubBh9WBN_dIeFoPLFbt1MKLwGBOpRFNn0130_provenance.